−10.46CAD
−69.11 MCAD
9.35 M
About APTOSE BIOSCIENCES INC
Sector
CEO
William G. Rice
Headquarters
Toronto
Website
Employees (FY)
35
Founded
1986
ISIN
CA03835T3091
FIGI
BBG000FYQ6V2
Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.
Aptos Biosciences APTO - Testing critical supportThis level should provide substantial support for a possible bounce. The risk/reward here is favorable for a long. Stop loss is essential, as always.
APTO Technical Analysis 🧙Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm
APTO Technical Analysis 🧙Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm
APTO Technical Analysis. 🧙Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of APS is 1.75 CAD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange APTOSE BIOSCIENCES INC stocks are traded under the ticker APS.
APTOSE BIOSCIENCES INC is going to release the next earnings report on May 7, 2024. Keep track of upcoming events with our Earnings Calendar.
APS stock is 6.32% volatile and has beta coefficient of −0.54. Check out the list of the most volatile stocks — is APTOSE BIOSCIENCES INC there?
One year price forecast for APTOSE BIOSCIENCES INC has a max estimate of 31.70 CAD and a min estimate of 6.89 CAD.
APS earnings for the last quarter are −2.39 CAD whereas the estimation was −2.79 CAD which accounts for 14.30% surprise. Estimated earnings for the next quarter are −2.11 CAD. See more details about APTOSE BIOSCIENCES INC earnings.
Yes, you can track APTOSE BIOSCIENCES INC financials in yearly and quarterly reports right on TradingView.
APS stock has fallen by 9.79% compared to the previous week, the month change is a 13.37% fall, over the last year APTOSE BIOSCIENCES INC has showed a 84.01% decrease.
APS net income for the last quarter is −16.28 M CAD, while the quarter before that showed −15.35 M CAD of net income which accounts for −6.05% change. Track more APTOSE BIOSCIENCES INC financial stats to get the full picture.
Today APTOSE BIOSCIENCES INC has the market capitalization of 27.51 M, it has decreased by 3.37% over the last week.
No, APS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, APS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade APTOSE BIOSCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 35.00 employees. See our rating of the largest employees — is APTOSE BIOSCIENCES INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So APTOSE BIOSCIENCES INC technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating APTOSE BIOSCIENCES INC stock shows the sell signal. See more of APTOSE BIOSCIENCES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on APTOSE BIOSCIENCES INC future price: according to them, APS price has a max estimate of 31.70 CAD and a min estimate of 6.89 CAD. Read a more detailed APTOSE BIOSCIENCES INC forecast: see what analysts think of APTOSE BIOSCIENCES INC and suggest that you do with its stocks.